# UNIVERSITY OF TX MD ANDERSON CAN CTR: Project 3: InHANCE: Fibrosis Imaging Biomarkers of Radiation: An Orphan Drug Study to Evaluate REduction of SeVERity of Symptoms in a Randomized Evaluative Trial (FIBRO2SE-REVERSE)

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF TX MD ANDERSON CAN CTR |
| Location | HOUSTON, TX |
| Project | Project 3: InHANCE: Fibrosis Imaging Biomarkers of Radiation: An Orphan Drug Study to Evaluate REduction of SeVERity of Symptoms in a Randomized Evaluative Trial (FIBRO2SE-REVERSE) |
| Project number | 5P01CA278716-02 |
| Mechanism | P01 |
| Institute | National Cancer Institute |
| Award | $421,623 |
| Awarded | 2026-09-02 |
| Project period | 2025-08-18 to 2030-07-31 |
| UEI | S3GMKS8ELA16 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11399820). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.